Skin at risk NonePrevention of periwound skin breakdown;

Protection from maceration Protect vulnerable or damaged areas Refer to site protocol

Askina® Barrier FilmAskina® Barrier Cream

1 - 3 days

Refer to site protocol

Protection and moisturising care for extremely dry, irritated skin

Linovera®Prevention of Stage I pressure ulcers

NoneSkin at risk

Your Guide for Wound Care

* in case of peripheral arterial disease, do not hydrate the wound

Skin at risk

Epithelialising wound

Granulating wound

Moist fibrinous wound

Black necrotic wound (non-ischemic) *

Infected wound

Granulating to epithelialising wound

Fibrinous to granulating wound

Dry fibrinous wound

Wound description / stage of wound healing

None

None

Medium

Medium to high

Low

Medium to high

Low

Medium to high

Low

Promotion of epithelialisation

Exudate management Promotion of granulation

Removal of fibrinous tissue Exudate management

Removal of dry necrotic tissue

Reduction of bacterial load Exudate managementOdour control

Absorption of remaining exudate; Promotion of epithelialisation

Removal of fibrinous tissue Exudate management Promotion of granulation

Removal of fibrinous tissue Prevention of infection

Therapeutic goalLevel of exudate

Topical application of rich, allergy tested moisture lotion

Protection of newly formed tissue

Wound cleansing, moist environment, protection of newly formed tissue and of surrounding skin

Mechanical or surgical debridement if needed, wound cleansing, enhancing moist environment to promote autolytic debridement

Hydration of the wound with hydrogelMechanical or surgical debridement

Wound cleansing, prevent contamination from external bacteria, enhance moist wound environment

Wound cleansing, protection of newly formed tissue and of surrounding skin

Wound cleansing, enhancing moist environment to promote autolytic debridement

Mechanical or surgical debridement if needed, wound cleansing, hydration of the wound

Procedure / actions

Refer to site protocol

Wound cleansing and wound bed preparation

Trixo-Lind®

Topical application

N/A

Cavity Dressings

Cavity Dressings

Askina® Gel

Silver Dressings

Cavity Dressings

Cavity Dressings

Askina® Gel

Askina® Biofilm Transparent Askina® Derm

Askina® SilNetAskina® DresSilAskina® Transorbent®

Askina® Absorb+Askina® Foam

Askina® Gel

Silver Dressings

Askina® SilNetAskina® DresSilAskina® Hydro

Askina® SilNetAskina® Absorb+Askina® Foam

Askina® Gel

N/A

Bandage, tape

Askina® Pad Bandage, tape

Askina® SilNet Askina® Derm

Askina® CarbosorbAskina® Pad Bandage, tape

Bandage, tape

Askina® Pad Bandage, tape

Askina® SilNet Askina® Derm

Secondary wound dressing

twice daily or as required

Frequency of application

up to 7 days

1 - 3 days

daily

up to 3 days

daily

3 - 5 days

1 - 3 days

1 - 3 days

Frequency of change

Deep

Primary wound dressing

Superficial

B. Braun Australia Pty Ltd | Bella Vista NSW 2153 | Tel: 1800 251 705 | Fax: 1800 628 045 | www.bbraun.com.au | info.au@bbraun.com© 2014 B. Braun Australia Pty Ltd

Topical application of Essential Fatty acids Diminish friction and shearing forces

twice daily

N/A

Prontosan® Wound Irrigation SolutionProntosan® Wound Gel

Prontosan® Wound Irrigation SolutionProntosan® Wound Gel

Prontosan® Wound Irrigation SolutionProntosan® Wound Gel

Wound Antisepsis

Prontosan® Wound Irrigation SolutionProntosan® Wound Gel

Prontosan® Wound Irrigation SolutionProntosan® Wound Gel

Prontosan® Wound Irrigation SolutionProntosan® Wound Gel

Skin Cleansing